For example, STING agonist diABZI can achieve therapeutic effect in a transgenic mice model of SARS-CoV-2 infection at the 0.5 mg kg−1 body weight dose level when administered intranasally, much lower than its treatment dose 1.5 mg kg−1 body weight in mouse model of colon cancer. The gene discussed is STING1; the disease is malignant colon neoplasm.